The Patent Finder

Urogen Pharma Ltd.

Also on record
Records under this name other than the patents Urogen Pharma Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.

Showing 1 to 8 of 8 · Back to Urogen Pharma Ltd.

PatentTitleStatus Expires Confidence
US 12,268,745Material and Method for Treating Internal Cavities
Term ended
Term ended Oct 26, 2026 · High confidence
Term endedTerm ended Oct 26, 2026High confidence
US 12,440,568Material and Method for Treating Internal Cavities
Term ended
Term ended Oct 26, 2026 · High confidence
Term endedTerm ended Oct 26, 2026High confidence
US 8,361,490Biocompatible Drug Delivery Apparatus and Methods
Term ended
Term ended Mar 26, 2026 · High confidence
Term endedTerm ended Mar 26, 2026High confidence
US 8,936,566Biocompatible Drug Delivery Apparatus and Methods
Term ended
Term ended Sep 16, 2024 · High confidence
Term endedTerm ended Sep 16, 2024High confidence
US 9,011,411Methods for Treatment of Bladder Cancer
Term ended
Term ended Sep 16, 2024 · High confidence
Term endedTerm ended Sep 16, 2024High confidence
US 9,884,028Methods for Treatment of Bladder Cancer
Term ended
Term ended Sep 16, 2024 · High confidence
Term endedTerm ended Sep 16, 2024High confidence
US 9,173,935Phospholipid Drug Analogs
Lapsed on the fee record
Ended Nov 3, 2023 · Medium confidence
Lapsed on the fee recordEnded Nov 3, 2023Medium confidence
US 9,050,319Phospholipid Drug Analogs
Lapsed on the fee record
Ended Jun 9, 2023 · Medium confidence
Lapsed on the fee recordEnded Jun 9, 2023Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited